ELIZABETH YUN: Open Payments
NPI 1316417181 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,347 in 131 payments from 15 companies in 2025. Trend: 2023 $475 · 2024 $919 · 2025 $2,347
Food & beverage: $2,137Education: $210
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $477 |
| GENZYME CORPORATION | 20 | $407 |
| ABBVIE INC. | 13 | $260 |
| Incyte Corporation | 20 | $256 |
| UCB, Inc. | 8 | $194 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $170 |
| Arcutis Biotherapeutics, Inc. | 17 | $156 |
| Organon LLC | 7 | $126 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| Lilly USA, LLC | 2 | $62 |
Products named: DUPIXENT, TREMFYA, OPZELURA, Bimzelx, SKYRIZI, Cabtreo, Zoryve, RINVOQ.
Industry payments across WA — which companies pay providers there.
